2015-2027 Global Checkpoint Inhibitors For Treating Cancer Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

March 2020 | 118 pages | ID: 2273D1BED1C0EN
Maia Research

Abstracts

The worldwide market for Checkpoint Inhibitors For Treating Cancer is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
Roche
PD-1 Inhibitors
Merck
PD-L1 Inhibitors
CTLA-4 Inhibitors
Bristol-Myers Squibb(BMS)

Major Types Covered
CTLA-4 inhibitors
PD-L1 inhibitors
PD-1 inhibitors

Major Applications Covered
Bladder cancer treatment
Melanoma treatment
Others

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027

Contents

1 INTRODUCTION

1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
  1.3.1 Market Segment by Type, Application and Marketing Channel
  1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 KEY FINDINGS OF THE STUDY

3 MARKET DYNAMICS

3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Checkpoint Inhibitors For Treating Cancer Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Checkpoint Inhibitors For Treating Cancer Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 VALUE CHAIN OF THE CHECKPOINT INHIBITORS FOR TREATING CANCER MARKET

4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 GLOBAL CHECKPOINT INHIBITORS FOR TREATING CANCER MARKET-SEGMENTATION BY TYPE

5.1 CTLA-4 inhibitors
5.2 PD-L1 inhibitors
5.3 PD-1 inhibitors

6 GLOBAL CHECKPOINT INHIBITORS FOR TREATING CANCER MARKET-SEGMENTATION BY APPLICATION

6.1 Bladder cancer treatment
6.2 Melanoma treatment
6.3 Others

7 GLOBAL CHECKPOINT INHIBITORS FOR TREATING CANCER MARKET-SEGMENTATION BY MARKETING CHANNEL

7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES

8.1 Roche
  8.1.1 Roche Profile
  8.1.2 Roche Sales, Growth Rate and Global Market Share from 2015-2020
  8.1.3 Roche Product/Solution Launches and Enhancements Analysis
  8.1.4 Roche Business Overview/Recent Development/Acquisitions
8.2 PD-1 Inhibitors
  8.2.1 PD-1 Inhibitors Profile
  8.2.2 PD-1 Inhibitors Sales, Growth Rate and Global Market Share from 2015-2020
  8.2.3 PD-1 Inhibitors Product/Solution Launches and Enhancements Analysis
  8.2.4 PD-1 Inhibitors Business Overview/Recent Development/Acquisitions
8.3 Merck
  8.3.1 Merck Profile
  8.3.2 Merck Sales, Growth Rate and Global Market Share from 2015-2020
  8.3.3 Merck Product/Solution Launches and Enhancements Analysis
  8.3.4 Merck Business Overview/Recent Development/Acquisitions
8.4 PD-L1 Inhibitors
  8.4.1 PD-L1 Inhibitors Profile
  8.4.2 PD-L1 Inhibitors Sales, Growth Rate and Global Market Share from 2015-2020
  8.4.3 PD-L1 Inhibitors Product/Solution Launches and Enhancements Analysis
  8.4.4 PD-L1 Inhibitors Business Overview/Recent Development/Acquisitions
8.5 CTLA-4 Inhibitors
  8.5.1 CTLA-4 Inhibitors Profile
  8.5.2 CTLA-4 Inhibitors Sales, Growth Rate and Global Market Share from 2015-2020
  8.5.3 CTLA-4 Inhibitors Product/Solution Launches and Enhancements Analysis
  8.5.4 CTLA-4 Inhibitors Business Overview/Recent Development/Acquisitions
8.6 Bristol-Myers Squibb(BMS)
  8.6.1 Bristol-Myers Squibb(BMS) Profile
  8.6.2 Bristol-Myers Squibb(BMS) Sales, Growth Rate and Global Market Share from 2015-2020
  8.6.3 Bristol-Myers Squibb(BMS) Product/Solution Launches and Enhancements Analysis
  8.6.4 Bristol-Myers Squibb(BMS) Business Overview/Recent Development/Acquisitions

9 GLOBAL CHECKPOINT INHIBITORS FOR TREATING CANCER MARKET-SEGMENTATION BY GEOGRAPHY

10 NORTH AMERICA

10.1 North America Checkpoint Inhibitors For Treating Cancer Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Checkpoint Inhibitors For Treating Cancer Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Checkpoint Inhibitors For Treating Cancer Production Analysis from 2015-2020
10.4 North America Checkpoint Inhibitors For Treating Cancer Consumption Analysis from 2015-2020
10.5 North America Checkpoint Inhibitors For Treating Cancer Import and Export from 2015-2020
10.6 North America Checkpoint Inhibitors For Treating Cancer Value, Production and Market Share by Type (2015-2020)
10.7 North America Checkpoint Inhibitors For Treating Cancer Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Checkpoint Inhibitors For Treating Cancer by Country (United States, Canada)
  10.8.1 North America Checkpoint Inhibitors For Treating Cancer Sales by Country (2015-2020)
  10.8.2 North America Checkpoint Inhibitors For Treating Cancer Consumption Value by Country (2015-2020)
10.9 North America Checkpoint Inhibitors For Treating Cancer Market PEST Analysis

11 EUROPE

11.1 Europe Checkpoint Inhibitors For Treating Cancer Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Checkpoint Inhibitors For Treating Cancer Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Checkpoint Inhibitors For Treating Cancer Production Analysis from 2015-2020
11.4 Europe Checkpoint Inhibitors For Treating Cancer Consumption Analysis from 2015-2020
11.5 Europe Checkpoint Inhibitors For Treating Cancer Import and Export from 2015-2020
11.6 Europe Checkpoint Inhibitors For Treating Cancer Value, Production and Market Share by Type (2015-2020)
11.7 Europe Checkpoint Inhibitors For Treating Cancer Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Checkpoint Inhibitors For Treating Cancer by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
  11.8.1 Europe Checkpoint Inhibitors For Treating Cancer Sales by Country (2015-2020)
  11.8.2 Europe Checkpoint Inhibitors For Treating Cancer Consumption Value by Country (2015-2020)
11.9 Europe Checkpoint Inhibitors For Treating Cancer Market PEST Analysis

12 ASIA-PACIFIC

12.1 Asia-Pacific Checkpoint Inhibitors For Treating Cancer Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Checkpoint Inhibitors For Treating Cancer Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Checkpoint Inhibitors For Treating Cancer Production Analysis from 2015-2020
12.4 Asia-Pacific Checkpoint Inhibitors For Treating Cancer Consumption Analysis from 2015-2020
12.5 Asia-Pacific Checkpoint Inhibitors For Treating Cancer Import and Export from 2015-2020
12.6 Asia-Pacific Checkpoint Inhibitors For Treating Cancer Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Checkpoint Inhibitors For Treating Cancer Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Checkpoint Inhibitors For Treating Cancer by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
  12.8.1 Asia-Pacific Checkpoint Inhibitors For Treating Cancer Sales by Country (2015-2020)
  12.8.2 Asia-Pacific Checkpoint Inhibitors For Treating Cancer Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Checkpoint Inhibitors For Treating Cancer Market PEST Analysis

13 LATIN AMERICA

13.1 Latin America Checkpoint Inhibitors For Treating Cancer Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Checkpoint Inhibitors For Treating Cancer Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Checkpoint Inhibitors For Treating Cancer Production Analysis from 2015-2020
13.4 Latin America Checkpoint Inhibitors For Treating Cancer Consumption Analysis from 2015-2020
13.5 Latin America Checkpoint Inhibitors For Treating Cancer Import and Export from 2015-2020
13.6 Latin America Checkpoint Inhibitors For Treating Cancer Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Checkpoint Inhibitors For Treating Cancer Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Checkpoint Inhibitors For Treating Cancer by Country (Brazil, Mexico, Argentina, Columbia, Chile)
  13.8.1 Latin America Checkpoint Inhibitors For Treating Cancer Sales by Country (2015-2020)
  13.8.2 Latin America Checkpoint Inhibitors For Treating Cancer Consumption Value by Country (2015-2020)
13.9 Latin America Checkpoint Inhibitors For Treating Cancer Market PEST Analysis

14 MIDDLE EAST & AFRICA

14.1 Middle East & Africa Checkpoint Inhibitors For Treating Cancer Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Checkpoint Inhibitors For Treating Cancer Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Checkpoint Inhibitors For Treating Cancer Production Analysis from 2015-2020
14.4 Middle East & Africa Checkpoint Inhibitors For Treating Cancer Consumption Analysis from 2015-2020
14.5 Middle East & Africa Checkpoint Inhibitors For Treating Cancer Import and Export from 2015-2020
14.6 Middle East & Africa Checkpoint Inhibitors For Treating Cancer Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Checkpoint Inhibitors For Treating Cancer Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Checkpoint Inhibitors For Treating Cancer by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
  14.8.1 Middle East & Africa Checkpoint Inhibitors For Treating Cancer Sales by Country (2015-2020)
  14.8.2 Middle East & Africa Checkpoint Inhibitors For Treating Cancer Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Checkpoint Inhibitors For Treating Cancer Market PEST Analysis

15 FUTURE FORECAST OF THE GLOBAL CHECKPOINT INHIBITORS FOR TREATING CANCER MARKET FROM 2020-2027

15.1 Future Forecast of the Global Checkpoint Inhibitors For Treating Cancer Market from 2020-2027 Segment by Region
15.2 Global Checkpoint Inhibitors For Treating Cancer Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Checkpoint Inhibitors For Treating Cancer Consumption and Growth Rate Forecast by Application (2020-2027)

16 APPENDIX

16.1 Methodology
16.2 Research Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Global Checkpoint Inhibitors For Treating Cancer Market Value ($) and Growth Rate of Checkpoint Inhibitors For Treating Cancer from 2015-2027
Global Checkpoint Inhibitors For Treating Cancer Production and Growth Rate Segment by Product Type from 2015-2027
Global Checkpoint Inhibitors For Treating Cancer Consumption and Growth Rate Segment by Application from 2015-2027
Figure Checkpoint Inhibitors For Treating Cancer Picture
Table Product Specifications of Checkpoint Inhibitors For Treating Cancer
Table Driving Factors for this Market
Table Industry News of Checkpoint Inhibitors For Treating Cancer Market
Figure Value Chain Status of Checkpoint Inhibitors For Treating Cancer
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Checkpoint Inhibitors For Treating Cancer Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Checkpoint Inhibitors For Treating Cancer Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure CTLA-4 inhibitors of Checkpoint Inhibitors For Treating Cancer
Figure PD-L1 inhibitors of Checkpoint Inhibitors For Treating Cancer
Figure PD-1 inhibitors of Checkpoint Inhibitors For Treating Cancer
Table Global Checkpoint Inhibitors For Treating Cancer Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Checkpoint Inhibitors For Treating Cancer Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Bladder cancer treatment of Checkpoint Inhibitors For Treating Cancer
Figure Melanoma treatment of Checkpoint Inhibitors For Treating Cancer
Figure Others of Checkpoint Inhibitors For Treating Cancer
Table Global Checkpoint Inhibitors For Treating Cancer Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Checkpoint Inhibitors For Treating Cancer Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Checkpoint Inhibitors For Treating Cancer
Figure Online Channel of Checkpoint Inhibitors For Treating Cancer
Table Roche Profile (Company Name, Plants Distribution, Sales Region)
Figure Roche Sales and Growth Rate from 2015-2020
Figure Roche Revenue ($) and Global Market Share from 2015-2020
Table Roche Checkpoint Inhibitors For Treating Cancer Sales, Price, Revenue, Gross Margin (2015-2020)
Table PD-1 Inhibitors Profile (Company Name, Plants Distribution, Sales Region)
Figure PD-1 Inhibitors Sales and Growth Rate from 2015-2020
Figure PD-1 Inhibitors Revenue ($) and Global Market Share from 2015-2020
Table PD-1 Inhibitors Checkpoint Inhibitors For Treating Cancer Sales, Price, Revenue, Gross Margin (2015-2020)
Table Merck Profile (Company Name, Plants Distribution, Sales Region)
Figure Merck Sales and Growth Rate from 2015-2020
Figure Merck Revenue ($) and Global Market Share from 2015-2020
Table Merck Checkpoint Inhibitors For Treating Cancer Sales, Price, Revenue, Gross Margin (2015-2020)
Table PD-L1 Inhibitors Profile (Company Name, Plants Distribution, Sales Region)
Figure PD-L1 Inhibitors Sales and Growth Rate from 2015-2020
Figure PD-L1 Inhibitors Revenue ($) and Global Market Share from 2015-2020
Table PD-L1 Inhibitors Checkpoint Inhibitors For Treating Cancer Sales, Price, Revenue, Gross Margin (2015-2020)
Table CTLA-4 Inhibitors Profile (Company Name, Plants Distribution, Sales Region)
Figure CTLA-4 Inhibitors Sales and Growth Rate from 2015-2020
Figure CTLA-4 Inhibitors Revenue ($) and Global Market Share from 2015-2020
Table CTLA-4 Inhibitors Checkpoint Inhibitors For Treating Cancer Sales, Price, Revenue, Gross Margin (2015-2020)
Table Bristol-Myers Squibb(BMS) Profile (Company Name, Plants Distribution, Sales Region)
Figure Bristol-Myers Squibb(BMS) Sales and Growth Rate from 2015-2020
Figure Bristol-Myers Squibb(BMS) Revenue ($) and Global Market Share from 2015-2020
Table Bristol-Myers Squibb(BMS) Checkpoint Inhibitors For Treating Cancer Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Checkpoint Inhibitors For Treating Cancer Production Value ($) by Region from 2015-2020
Table Global Checkpoint Inhibitors For Treating Cancer Production Value Share by Region from 2015-2020
Table Global Checkpoint Inhibitors For Treating Cancer Production by Region from 2015-2020
Table Global Checkpoint Inhibitors For Treating Cancer Consumption Value ($) by Region from 2015-2020
Table Global Checkpoint Inhibitors For Treating Cancer Consumption by Region from 2015-2020
Table North America Checkpoint Inhibitors For Treating Cancer Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Checkpoint Inhibitors For Treating Cancer Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Checkpoint Inhibitors For Treating Cancer Import and Export from 2015-2020
Table North America Checkpoint Inhibitors For Treating Cancer Value ($) by Type (2015-2020)
Table North America Checkpoint Inhibitors For Treating Cancer Production by Type (2015-2020)
Table North America Checkpoint Inhibitors For Treating Cancer Consumption by Application (2015-2020)
Table North America Checkpoint Inhibitors For Treating Cancer Consumption by Country (2015-2020)
Table North America Checkpoint Inhibitors For Treating Cancer Consumption Value ($) by Country (2015-2020)
Figure North America Checkpoint Inhibitors For Treating Cancer Market PEST Analysis
Table Europe Checkpoint Inhibitors For Treating Cancer Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Checkpoint Inhibitors For Treating Cancer Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Checkpoint Inhibitors For Treating Cancer Import and Export from 2015-2020
Table Europe Checkpoint Inhibitors For Treating Cancer Value ($) by Type (2015-2020)
Table Europe Checkpoint Inhibitors For Treating Cancer Production by Type (2015-2020)
Table Europe Checkpoint Inhibitors For Treating Cancer Consumption by Application (2015-2020)
Table Europe Checkpoint Inhibitors For Treating Cancer Consumption by Country (2015-2020)
Table Europe Checkpoint Inhibitors For Treating Cancer Consumption Value ($) by Country (2015-2020)
Figure Europe Checkpoint Inhibitors For Treating Cancer Market PEST Analysis
Table Asia-Pacific Checkpoint Inhibitors For Treating Cancer Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Checkpoint Inhibitors For Treating Cancer Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Checkpoint Inhibitors For Treating Cancer Import and Export from 2015-2020
Table Asia-Pacific Checkpoint Inhibitors For Treating Cancer Value ($) by Type (2015-2020)
Table Asia-Pacific Checkpoint Inhibitors For Treating Cancer Production by Type (2015-2020)
Table Asia-Pacific Checkpoint Inhibitors For Treating Cancer Consumption by Application (2015-2020)
Table Asia-Pacific Checkpoint Inhibitors For Treating Cancer Consumption by Country (2015-2020)
Table Asia-Pacific Checkpoint Inhibitors For Treating Cancer Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Checkpoint Inhibitors For Treating Cancer Market PEST Analysis
Table Latin America Checkpoint Inhibitors For Treating Cancer Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Checkpoint Inhibitors For Treating Cancer Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Checkpoint Inhibitors For Treating Cancer Import and Export from 2015-2020
Table Latin America Checkpoint Inhibitors For Treating Cancer Value ($) by Type (2015-2020)
Table Latin America Checkpoint Inhibitors For Treating Cancer Production by Type (2015-2020)
Table Latin America Checkpoint Inhibitors For Treating Cancer Consumption by Application (2015-2020)
Table Latin America Checkpoint Inhibitors For Treating Cancer Consumption by Country (2015-2020)
Table Latin America Checkpoint Inhibitors For Treating Cancer Consumption Value ($) by Country (2015-2020)
Figure Latin America Checkpoint Inhibitors For Treating Cancer Market PEST Analysis
Table Middle East & Africa Checkpoint Inhibitors For Treating Cancer Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Checkpoint Inhibitors For Treating Cancer Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Checkpoint Inhibitors For Treating Cancer Import and Export from 2015-2020
Table Middle East & Africa Checkpoint Inhibitors For Treating Cancer Value ($) by Type (2015-2020)
Table Middle East & Africa Checkpoint Inhibitors For Treating Cancer Production by Type (2015-2020)
Table Middle East & Africa Checkpoint Inhibitors For Treating Cancer Consumption by Application (2015-2020)
Table Middle East & Africa Checkpoint Inhibitors For Treating Cancer Consumption by Country (2015-2020)
Table Middle East & Africa Checkpoint Inhibitors For Treating Cancer Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Checkpoint Inhibitors For Treating Cancer Market PEST Analysis
Table Global Checkpoint Inhibitors For Treating Cancer Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Checkpoint Inhibitors For Treating Cancer Production and Growth Rate Forecast by Region (2020-2027)
Table Global Checkpoint Inhibitors For Treating Cancer Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Checkpoint Inhibitors For Treating Cancer Production and Growth Rate Forecast by Type (2020-2027)
Table Global Checkpoint Inhibitors For Treating Cancer Consumption and Growth Rate Forecast by Application (2020-2027)